Michael Plank, University of Canterbury; Shaun Hendy, University of Auckland, and Siouxsie Wiles, University of …
Read More »Ebos outlook subdued after Symbion acquisition driven profit boost
Ebos Group is unlikely to repeat a trebling of annual profit fuelled by last year acquisition of the Symbion pharmaceutical wholesaler and distributor in Australia, where regulatory changes are putting pressure on the sector. The $1.1 billion cash and scrip Symbion purchase in June 2013 was a game-changer for the Christchurch-based healthcare and animal care manufacturer company, more than tripling annual revenue in a deal that gave Symbion’s …
Read More »
newzealandinc.com Informed. Influential. Indispensable.






